
Ricard Cervera
Autoimmune Diseases Head of DepartmentResearch group
- Systemic autoimmune diseases Group leader (R4)
About me
Ricard Cervera, MD, PhD, FRCP is Senior Consultant and Head at the Department of Autoimmune Diseases, Hospital Clínic de Barcelona, Director of the Research Group on Systemic Autoimmune Diseases at the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) of Barcelona, Professor and Director of the UB-GSK Chair on Autoimmune Diseases, Coordinator of the Masters’ on Autoimmune Diseases and Academic Vice-Dean at the Faculty of Medicine and Health Sciences of the University of Barcelona (UB).
Featured publications
-
Anti Ro52 antibodies: One step further, but still not there yet
Authors: Ríos-Garcés R, Cervera R .Reference: European Journal Of Internal Medicine 2021. -
The impact of antimalarial agents on traditional and non-traditional subclinical atherosclerosis biomarkers in systemic lupus erythematosus: A systematic review and meta-analysis
Authors: Munguía-Realpozo P; Mendoza-Pinto C; García-Carrasco M; Berra-Romani R; Sierra-Benito C; Méndez-Martínez S; Cervera R.Reference: Autoimmunity Reviews 2021. -
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome
Authors: Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, Jamin C, Barturen G, Desachy G, Devauchelle-Pensec V, Boudjeniba C, Cornec D, Saraux A, Jousse-Joulin S, Barbarroja N, Rodríguez-Pintó I, De Langhe E, Beretta L, Chizzolini C, Kovács L, Witte T,, Bettacchioli E, Buttgereit A, Makowska Z, Lesche R, Borghi MO, Martin J, Courtade-Gaiani S, Xuereb L, Guedj M, Moingeon P, Alarcón-Riquelme ME, Laigle L, Pers JO PRECISESADS Clinical Consortium, PRECISESADS Flow Cytometry Consortium.Reference: Nature Communications 2021. -
European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance
Authors: Aringer M, Brinks R, Dörner T, Daikh D, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstrøm K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Schmajuk G, Tani C, Tedeschi SK, Touma Z, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirják L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kumánovics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, Rúa-Figueroa Í, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, Costenbader K, Johnson SR .Reference: Annals Of The Rheumatic Diseases 2021. -
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases
Authors: Barturen G, Babaei S, Català-Moll F, Martínez-Bueno M, Makowska Z, Martorell-Marugán J, Carmona-Sáez P, Toro-Domínguez D, Carnero-Montoro E, Teruel M, Kerick M, Acosta-Herrera M, Le Lann L, Jamin C, Rodríguez-Ubreva J, García-Gómez A, Kageyama J, Buttgereit A, Hayat S, Mueller J, Lesche R, Hernandez-Fuentes M, Juarez M, Rowley T, White I, Marañón C, Gomes Anjos T, Varela N, Aguilar-Quesada R, Garrancho FJ, López-Berrio A, Rodriguez Maresca M, Navarro-Linares H, Almeida I, Azevedo N, Brandão M, Campar A, Faria R, Farinha F, Marinho A, Neves E, Tavares A, Vasconcelos C, Trombetta E, Montanelli G, Vigone B, Alvarez-Errico D, Li T, Thiagaran D, Blanco Alonso R, Corrales Martínez A, Genre F, López Mejías R, Gonzalez-Gay MA, Remuzgo S, Ubilla Garcia B, Cervera R, Espinosa G, Rodríguez-Pintó I, De Langhe E, Cremer J, Lories R, Belz D, Hunzelmann N, Baerlecken N, Kniesch K, Witte T, Lehner M, Stummvoll G, Zauner M, Aguirre-Zamorano MA, Barbarroja N, Castro-Villegas MC, Collantes-Estevez E, de Ramon E, Díaz Quintero I, Escudero-Contreras A, Fernández Roldán MC, Jiménez Gómez Y, Jiménez Moleón I, Lopez-Pedrera R, Ortega-Castro R, Ortego N, Raya E, Artusi C, Gerosa M, Meroni PL, Schioppo T, De Groof A, Ducreux J, Lauwerys B, Maudoux AL, Cornec D, Devauchelle-Pensec V, Jousse-Joulin S, Jouve PE, Rouvière B, Saraux A, Simon Q, Alvarez M, Chizzolini C, Dufour A, Wynar D, Balog A, Bocskai M, Deák M, Dulic S, Kádár G, Kovács L, Cheng Q, Gerl V, Hiepe F, Khodadadi L, Thiel S, de Rinaldis E, Rao S, Benschop RJ, Chamberlain C, Dow ER, Ioannou Y, Laigle L, Marovac J, Wojcik J, Renaudineau Y, Borghi MO, Frostegård J, Martín J, Beretta L, Ballestar E, McDonald F, Pers JO, Alarcón-Riquelme ME .Reference: Arthritis & Rheumatology 2021. -
Understanding tubulointerstitial injury and repair mechanisms paves the way for renal outcome improvement in lupus nephritis
Authors: Xipell M; Egan A; Lledó G; Villarreal JZ; Espinosa G; García-Herrera A; Cervera R; Jayne D; Quintana LF.Reference: Revista Colombiana De Reumatologia 2021. -
Management of patients with antiphospholipid antibodies: what to do in laboratory scenarios that do not fit the guidelines
Authors: Pires Da Rosa G, Rodríguez-Pintó I, Cervera R, Espinosa G .Reference: Expert Review Of Hematology 2021. -
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature
Authors: Moroni L, Righini P, Ramirez GA, Farina N, Mancuso G, Bozzolo E, Rodríguez-Pintó I, Cervera R, Nano G, Dagna L .Reference: Lupus 2021. -
What are the topics you care about making trials in lupus more effective? Results of an Open Space meeting of international lupus experts
Authors: Mucke J, Alarcon-Riquelme M, Andersen J, Aringer M, Bombardieri S, Brinks R, Cervera R, Chehab G, Cornet A, Costedoat-Chalumeau N, Czirják L, Doria A, Fischer-Betz R, Furie RA, Gatto M, Houssiau FA, Ines L, Liang MH, Morand E, Mosca M, Pego-Reigosa JM, Rúa-Figueroa I, Ruiz-Irastorza G, Terrier B, Voss A, Schneider M .Reference: Lupus Science And Medicine 2021.
Featured Projects
-
Desarrollo de un protocolo ELISPOT para la determinación y cuantificación de linfocitos B productores de anticuerpos anti-DNA de doble cadena en lupus eritematoso sistémico.
Principal investigator: R. CerveraFunder: Hospital Clinic de Barcelona (Sede); Hospital Clinic de Barcelona ; Hospital Clinic de Barcelona (Participante)Duration: 01/06/2017 - 01/06/2018 -
Estudio de nuevos antígenos en esclerodermia
Principal investigator: R. CerveraFunder: Hospital Clinic de Barcelona (Sede); Instituto de Salud Carlos III ; Hospital Clinic de Barcelona (Participante)Duration: 01/01/2017 - 01/12/2017 -
Síndromes linfoproliferativos asociados a inmunodeficiencia. Estudio clínico-patologico del papel de la replicación de los virus herpes oncogénicos y de la diferenciación plasmocelular. Identificación
Principal investigator: Premi Fi de Residència de l'Hospital Clínic de BarcelonaDuration: 01/01/2014 -
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases Mechanisms for the Improvement of Drug Development and Therapy (PRECISESADS).
Principal investigator: Ricard CerveraCode: 115565-3Duration: 01/01/2013 - 01/01/2018 -
Fenotipo pro y anticoagulante de las micropartículas circulantes en la patología trombótica arterial de las enfermedades autoinmunes.
Principal investigator: Gerard EspinossaDuration: 01/01/2013 - 01/01/2014